 NEWTON, Mass., May 05, 2022 GLOBE NEWSWIRE -- Acer Therapeutics Inc. Nasdaq: ACER, a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that Acers management team will virtually present at, and participate in, the H.C. Wainwright Global Investment Conference May 24-26, 2022. 